InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.435
+0.015 (0.62%)
At close: Oct 8, 2025, 4:00 PM EDT
2.440
+0.005 (0.21%)
After-hours: Oct 8, 2025, 6:06 PM EDT
InspireMD Revenue
InspireMD had revenue of $1.78M in the quarter ending June 30, 2025, with 2.24% growth. This brings the company's revenue in the last twelve months to $7.07M, up 7.60% year-over-year. In the year 2024, InspireMD had annual revenue of $7.01M with 12.96% growth.
Revenue (ttm)
$7.07M
Revenue Growth
+7.60%
P/S Ratio
17.01
Revenue / Employee
$82,163
Employees
86
Market Cap
101.59M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
NSPR News
- 13 hours ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 21 days ago - InspireMD Announces the Appointment of Dan Dearen to its Board of Directors - GlobeNewsWire
- 6 weeks ago - InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 2 months ago - InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - InspireMD Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors - GlobeNewsWire
- 2 months ago - InspireMD Announces Combined Financings of $58 Million - GlobeNewsWire
- 2 months ago - InspireMD to Announce Second Quarter 2025 Financial Results - GlobeNewsWire